11598
T. D. Lash, S. Chen / Tetrahedron 61 (2005) 11577–11600
1
1
(m), 141.5 (d, JNCZ13.3 Hz), 141.6 (d, JNCZ13.3 Hz),
142.3 (d, 1JNCZ13.2 Hz), 142.4 (d, 1JNCZ13.3 Hz), 144.3–
144.4 (m); EI MS: m/z (rel int.): 484 (6), 483 (34), 482 (100)
(MC), 468 (8), 467 (25), 452 (6), 241 (22), 226 (9), 219 (6).
C34H46N4Br2$H2O: C, 59.30; H, 7.02; N, 8.14. Found: C,
59.22; H, 6.77; N, 8.10. 15N labeled 38. Using the same
procedure, 160 mg (0.38 mmol) of labeled dipyrrylmethane
36 and 108 mg (0.71 mmol) of labeled pyrrole aldehyde 13
gave the required a,c-biladiene (186 mg; 0.276 mmol; 77%)
as a brick red solid. 1H NMR (CDCl3): d 0.70 (3H, t, 3JHH
Z
7.4 Hz), 1.08 (6H, two overlapping triplets), 1.68 (4H, m),
4.2.6. Synthesis of butanoporphyrin 8.
4.2.6.1. Butyl 3,4-butano-50-ethoxycarbonyl-40-ethyl-
30-methyl-2,20-dipyrrylmethane-5-carboxylate (36).
Montmorillonite clay (K-10, 2.70 g) was added to a stirred
solution of acetoxymethylpyrrole 20 (253 mg; 1.00 mmol)
and n-butyl 4,5,6,7-tetrahydro-2H-isoindole-1-carboxylate
(25)17 (221 mg, 1.00 mmol) in dichloromethane (40 mL).
The mixture was stirred vigorously overnight at room
temperature. The clay was removed by suction filtration and
the solvent evaporated over reduced pressure to give a pink
solid. The residue was purified by flash chromatography
eluting with 5% ethyl acetate/toluene and recrystallized
from ethanol to give the title dipyrrylmethane (260 mg;
2.25 (3H, s), 2.26 (3H, s), 2.29 (3H, s), 2.41–2.49 (4H, m),
Z
3
2.66 (2H, m), 2.70 (6H, two overlapping doublets, JNH
3 Hz), 5.15 (2H, s), 6.98 (1H, t, 3JNHZ5.2 Hz), 7.07 (1H, t,
3JNHZ5.0 Hz), 13.06 (1H, d, 1JNHZK94.8 Hz), 13.14 (1H,
1
1
d, JNHZK94.8 Hz), 13.23 (1H, d, JNHZK95.2 Hz),
1
13.33 (1H, d, JNHZ K94.4 Hz).
4.2.6.3. 2,3-Butano-7,13,17-triethyl-8,12,18-trimethyl-
porphyrin (8). a,c-Biladiene dihydrobromide (38) (70 mg;
0.104 mmol) was added to a stirred solution of copper(II)
chloride (0.15 g) in DMF (45 mL). The flask was covered
with aluminum foil and the solution stirred at room
temperature for 2.5 h. The solution was diluted with
chloroform (50 mL) and washed with water (3!50 mL).
The combined organic layers were then dried over sodium
sulfate, filtered and the solvent evaporated under vacuum.
The dark purple residue was taken up in 15% (v/v) sulfuric
acid/trifluroacetic acid (6 mL) and stirred at room tempera-
ture for 45 min. The solution was diluted with water,
extracted with chloroform and washed with 5% aqueous
sodium bicarbonate solution, and the solvent evaporated
under reduced pressure to give a dark solid. The residue was
chromatographed on grade III alumina, eluting with
dichloromethane, and recrystallized from chloroform/
methanol to give the tetrahydrobenzoporphyrin (20 mg;
0.041 mmol; 40%) as a purple solid, mp O300 8C. 1H NMR
(CDCl3): d K3.76 (2H, s), 1.84–1.90 (9H, three overlapping
triplets), 2.53 (4H, m), 3.62 (3H, s), 3.64 (6H, s), 4.05–4.14
(6H, three overlapping quartets), 4.16 (4H, m), 9.98 (1H, s),
9.99 (1H, s), 10.09 (1H, s), 10.11 (1H, s); 1H NMR
(TFA–CDCl3): d K3.89 (1H, br s), K3.84 (2H, br s),
K3.73 (1H, br s), 1.70–1.76 (9H, three overlapping triplets),
2.56 (4H, m), 3.66 (3H, s), 3.67 (6H, s), 4.10–4.18 (10H, m),
10.56 (2H, s), 10.65 (1H, s), 10.66 (1H, s); 9.98 (1H, s), 9.99
(1H, s), 10.09 (1H, s), 10.11 (1H, s); 13C NMR
(TFA–CDCl3): d 12.0, 16.6 (2), 16.7, 20.3 (2), 22.7, 23.5,
98.1, 98.2, 98.4, 99.0, 137.6, 137.7, 138.0, 141.2 (2), 141.3,
141.7, 141.8 (2), 142.0, 142.1, 142.5, 144.2, 144.5; EI MS:
m/z (rel int.) 492 (7), 491 (38), 490 (100) (MC), 478 (5), 476
(8), 475 (22), 246 (10), 245 (27), 230 (6), 223 (5), 216 (5).
1
0.63 mmol; 63%) as white crystals, mp 114–115 8C. H
NMR (CDCl3): d 0.90 (3H, t), 1.03 (3H, t), 1.32 (3H, t), 1.41
(2H, m), 1.66 (2H, m), 1.72 (4H, m), 2.28 (3H, s), 2.40 (2H,
m), 2.77 (2H, q), 3.82 (2H, s), 4.23 (4H, m), 8.75 (2H, br s);
13C NMR (CDCl3): d 10.7, 13.9, 14.7, 15.7, 17.5, 19.5, 21.5,
23.0, 23.4, 23.5, 23.6, 31.1, 60.1, 64.0, 116.7, 118.0, 119.2,
124.3, 127.1, 129.2, 129.3, 129.4, 162.2, 162.5. Anal. Calcd
for C24H34N2O4: C, 69.47; H, 8.26; N, 6.75. Found: C,
69.35; H, 7.77; N, 6.67. 15N labeled 36. 1H NMR (CDCl3): d
0.93 (3H, t, 3JHHZ7.2 Hz), 1.03 (3H, t, 3JHHZ7.4 Hz), 1.32
3
(3H, t, JHHZ7.2 Hz), 1.36–1.47 (2H, m), 1.64–1.71 (2H,
m), 1.72–1.76 (4H, m), 2.28 (3H, s), 2.37–2.43 (4H, m),
3
2.77 (2H, br t), 3.82 (2H, t, JNHZ2.6 Hz), 4.21 (2H, t,
3JHHZ6.6 Hz), 4.27 (2H, q, JHHZ7.2 Hz), 8.59 (1H, d,
3
1JNHZK97 Hz), 8.62 (1H, d, JNHZK97 Hz); 13C NMR
(CDCl3): d 10.7, 13.9, 14.7, 15.7, 17.5, 19.5, 21.5, 22.9,
23.5, 23.6, 31.1, 60.1, 64.0, 116.7 (d, 1JNCZ15.5 Hz), 118.0
1
2
(d, JNCZ14.8 Hz), 119.1 (d, JNCZ3.8 Hz), 124.2 (d,
2JNCZ3.8 Hz), 127.1 (d, JNCZ4.6 Hz), 129.3–129.5 (m),
162.3, 162.6.
2
4.2.6.2. 7,8-Butano-3,12,17-triethyl-1,2,13,18,19-
pentamethyl-10,23-dihydrobilin dihydrobromide (38).
Dipyrrylmethane (36) (91 mg; 0.22 mmol) was heated
with sodium hydroxide (1.00 g) and ethylene glycol
(10 mL) under reflux conditions for 30 min. The mixture
was diluted with water and extracted with hexane. The
hexane solution was dried over sodium sulfate and the
solvent evaporated under reduced pressure to give 37 as a
dark oil. A solution of 4-ethyl-3,5-dimethylpyrrole-2-
carboxaldehyde (13) (66 mg; 0.44 mmol) in methanol
(1.0 mL) was added and all residual material was washed
into the reaction flask with additional methanol (0.7 mL).
Hydrogen bromide in acetic acid (30%, 0.3 mL) was
immediately added and the mixture was stirred for 30 min
at room temperature. Anhydrous ether (15 mL) was added
dropwise after which the mixture was stirred at room
temperature for 2 h. The resulting precipitate was filtered
and rinsed with anhydrous ether to give the title a,c-
biladiene dihydrobromide as a brick red solid (96 mg;
0.143 mmol; 65%), mp 237 8C, dec. UV–vis: lmax: 374,
458, 528 nm; 1H NMR (CDCl3): d 0.71 (3H, t), 1.09 (6H, t),
1.69 (4H, m), 2.25–2.31 (11H, m), 2.46 (4H, m), 2.71 (6H,
s), 5.15 (2H, s), 7.00 (1H, s), 7.11 (1H, s), 13.04 (1H, s),
13.12 (1H, s), 13.20 (1H, s), 13.31 (1H, s). Anal. Calcd for
1
15N labeled 8. H NMR (CDCl3): d K3.79 (2H, quintet,
1JNHZK23 Hz), 1.83–1.89 (9H, three overlapping triplets),
2.53 (4H, m), 3.62 (3H, s), 3.64 (6H, s), 4.05–4.14 (6H, m),
4.16 (4H, m), 9.97–10.01 (2H, two overlapping triplets,
3JNHZ4 Hz), 10.07–10.13 (2H, two overlapping triplets,
1
3JNHZ4 Hz); H NMR (TFA–CDCl3): d K4.03 (2H, d,
1
1JNHZK94.8 Hz), K3.98 (1H, d, JNHZK94.0 Hz),
1
K3.87 (1H, d, JNHZ K94.0 Hz), 1.70–1.76 (9H, three
overlapping triplets), 2.56 (4H, m), 3.66 (3H, s), 3.67 (6H,
3
s), 4.11–4.19 (10H, m), 10.57 (1H, t, JNHZ5 Hz), 10.58
3
3
(1H, t, JNHZ4.8 Hz), 10.67 (1H, t, JNHZ5.2 Hz), 10.68
(1H, t, 3JNHZ5 Hz); 13C NMR (TFA–CDCl3): d 12.0, 16.6
(2), 16.7, 20.3 (2), 22.7, 23.5, 98.1, 98.3, 98.5, 99.0, 137.9,
1
138.0, 138.2, 141.0–142.1 (m), 142.5 (d, JNCZ13.2 Hz),
144.5, 144.8; EI MS: m/z (rel int.) 496 (7), 495 (36), 494